Form 4 for EBS Emergent BioSolutions Inc.

Accepted 2024-05-28 00:00:00 ET · period of report 2024-05-23 · accession 0001367644-24-000085 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-05-28	2024-05-23	EBS	Dayal Sujata Tyagi	Dir	A - Grant	$0.00	+17.4K	63.1K	+38%	$0
D	2024-05-28	2024-05-23	EBS	Dayal Sujata Tyagi	Dir	A - Grant	$0.00	+25.7K	25.7K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-05-23	A	A	17,430	$0.00	63,129	D	—	—	(F1) Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.
2	Derivative	Stock Option (Right to Buy)	2024-05-23	A	A	25,748	$0.00	25,748	D	$5.02 · — to 2031-05-22	25,748 Common Stock	(F2) Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.